Physician profile
John Schofield
NPI 1205811023
$2,824.65
in general payments reported to CMS, 2019-2025
19 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,066 · 2020: $369 · 2021: $544 · 2022: $271 · 2023: $237 · 2024: $219 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $556 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $556.22 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $799.00 | 2019-2024 | Hydrus Microstent, Clareon |
| Allergan, INC. | $572.63 | 2019-2022 | |
| Aerie Pharmaceuticals, INC. | $270.75 | 2019-2021 | |
| Abbvie INC. | $248.97 | 2022-2025 | Alphagan P, Lumigan, Vuity |
| Sight Sciences, INC. | $192.73 | 2019-2025 | Omni Surgical System, Sion Surgical Instrument |
| Thea Pharma INC. | $171.54 | 2022-2025 | Iyuzeh |
| Akorn Operating Company LLC | $113.61 | 2021 | |
| Akorn, INC. | $88.77 | 2019-2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $85.90 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $45.86 | 2019-2020 | |
| Kala Pharmaceuticals, INC. | $36.16 | 2020 | |
| Bausch & Lomb Americas INC. | $34.50 | 2022-2024 | Miebo |
| Mallinckrodt Hospital Products INC. | $31.60 | 2021 | |
| Dompe US, INC. | $29.82 | 2023 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $23.61 | 2024 | Xdemvy |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $22.00 | 2025 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Novartis Pharmaceuticals Corporation | $20.94 | 2019 | |
| Oyster Point Pharma, INC. | $19.02 | 2022 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Schofield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.